중합효소 연쇄 반응(PCR) 시장 규모, 점유율, 성장 분석 : 유형별, 제품별, 적응증별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Polymerase Chain Reaction (PCR) Market Size, Share, and Growth Analysis, By Type (Standard PCR, Real-time PCR), By Product (Instruments, Reagents & Consumables), By Indication, By End User, By Region - Industry Forecast 2025-2032
상품코드:1687634
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
중합효소 연쇄 반응(PCR) 시장 규모는 2023년에 101억 달러로 평가되며, 2024년 109억 5,000만 달러에서 2032년에는 208억 7,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 8.4%로 성장할 전망입니다.
세계 중합효소연쇄반응(PCR) 시장은 분자생물학 및 진단 분야에서 중요한 기술로 떠오르며 최근 수년간 괄목할 만한 성장세를 보이고 있으며, DNA 및 RNA 샘플의 증폭 및 분석에 필수적인 이 다용도한 방법은 연구, 임상 진단, 법의학, 생명공학에 적용되고 있습니다. 시장 확대의 주요 촉진요인으로는 감염성 질환 발병률 증가, 맞춤형 의료에 대한 수요, 유전체학의 발전, 신속하고 정확한 진단의 필요성(특히 COVID-19 팬데믹의 여파)을 들 수 있습니다. 시장에는 다양한 PCR 툴, 소모품, 서비스를 제공하는 수많은 선도 기업이 있습니다. 기존 기술은 실시간 PCR 및 디지털 PCR과 같은 보다 효율적이고 자동화된 솔루션으로 전환되고 있으며, 속도와 민감도가 향상되고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 상황
사례 연구
기술의 진보
중합효소 연쇄 반응(PCR) 시장 규모 : 유형별 & CAGR(2025-2032)
시장 개요
표준 PCR
실시간 PCR
디지털 PCR
중합효소 연쇄 반응(PCR) 시장 규모 : 제품별 & CAGR(2025-2032)
시장 개요
기기
시약·소모품
중합효소 연쇄 반응(PCR) 시장 규모 : 적응증별 & CAGR(2025-2032)
시장 개요
감염증
종양학
유전성 질환
기타
중합효소 연쇄 반응(PCR) 시장 규모 : 최종사용자별 & CAGR(2025-2032)
시장 개요
병원·클리닉
제약·바이오테크놀러지 산업
진단 센터
학술·조사기관
중합효소 연쇄 반응(PCR) 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Abbott Laboratories(USA)
Agilent Technologies(USA)
Thermo Fisher Scientific(USA)
Siemens Healthineers(Germany)
bioMerieux(France)
Becton, Dickinson and Company(USA)
Bio-Rad Laboratories(USA)
Merck KGaA(Germany)
PerkinElmer(USA)
Promega Corporation(USA)
Danaher Corporation(USA)
QIAGEN(Netherlands)
QuantuMDx Group Ltd(UK)
Eppendorf(Germany)
Fluidigm Corporation(USA)
Microsynth AG(Switzerland)
JN Medsys(Singapore)
Takara Bio Inc(Japan)
결론과 제안
KSA
영문 목차
영문목차
Polymerase Chain Reaction (PCR) Market size was valued at USD 10.1 billion in 2023 and is poised to grow from USD 10.95 billion in 2024 to USD 20.87 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).
The global polymerase chain reaction (PCR) market has seen remarkable growth recently, emerging as a crucial technology in molecular biology and diagnostics. This versatile method, essential for amplifying and analyzing DNA and RNA samples, finds applications across research, clinical diagnostics, forensics, and biotechnology. Key drivers of market expansion include rising rates of infectious diseases, the demand for personalized medicine, advancements in genomics, and the necessity for rapid, accurate diagnostics, particularly in the aftermath of the COVID-19 pandemic. The market boasts numerous leading players offering a diverse array of PCR tools, consumables, and services. Traditional techniques are shifting towards more efficient, automated solutions like real-time and digital PCR, enhancing speed and sensitivity, while portable devices broaden access to point-of-care applications.
Top-down and bottom-up approaches were used to estimate and validate the size of the Polymerase Chain Reaction (PCR) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Polymerase Chain Reaction (PCR) Market is segmented by Type, Product, Indication, End User and region. Based on Type, the market is segmented into Standard PCR, Real-time PCR and Digital PCR. Based on Product, the market is segmented into Instruments and Reagents & Consumables. Based on Indication, the market is segmented into Infectious Diseases, Oncology, Genetic Disorders and Others. Based on End User, the market is segmented into Hospitals & Clinics, Pharmaceutical & Biotechnology Industries, Diagnostic Centers and Academic & Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Polymerase Chain Reaction (PCR) Market
The Polymerase Chain Reaction (PCR) market is significantly influenced by its widespread application in molecular diagnostics for the detection and monitoring of various diseases, including infectious diseases, cancers, and genetic disorders. The COVID-19 pandemic has notably heightened the need for accurate and rapid diagnostic tools, leading to an increased demand for PCR-based tests and diagnostics. This trend is expected to persist, further propelling the growth of the PCR market as healthcare providers and laboratories seek reliable solutions to facilitate timely diagnosis and effective patient management in the face of evolving health challenges.
Restraints in the Polymerase Chain Reaction (PCR) Market
The Polymerase Chain Reaction (PCR) market faces significant challenges due to the high costs associated with PCR units and consumables. This financial burden poses a substantial barrier for smaller laboratories, clinics, and research institutions that may struggle to afford the necessary equipment and materials. As a result, the limited accessibility of PCR technology in resource-constrained environments restricts its adoption and utilization, which could hinder overall market growth, particularly in developing regions where healthcare budgets are often tight. Addressing these economic constraints is crucial for expanding PCR applications and fostering advancements in diagnostic and research capabilities.
Market Trends of the Polymerase Chain Reaction (PCR) Market
The Polymerase Chain Reaction (PCR) market is witnessing a significant trend towards Point-of-Care (POC) PCR testing solutions, fueled by the growing need for rapid and on-site diagnostic capabilities, particularly highlighted during the COVID-19 pandemic. Healthcare providers are increasingly prioritizing quick results, which are crucial for managing infectious disease outbreaks and improving patient outcomes. The surge in demand for convenient testing options has led to a proliferation of POC PCR devices and kits, enhancing accessibility for healthcare facilities and patients alike. This shift not only streamlines the diagnostic process but also positions the POC PCR segment as a key driver of market growth.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Global Polymerase Chain Reaction (PCR) Market Size by Type & CAGR (2025-2032)
Market Overview
Standard PCR
Real-time PCR
Digital PCR
Global Polymerase Chain Reaction (PCR) Market Size by Product & CAGR (2025-2032)
Market Overview
Instruments
Reagents & Consumables
Global Polymerase Chain Reaction (PCR) Market Size by Indication & CAGR (2025-2032)
Market Overview
Infectious Diseases
Oncology
Genetic Disorders
Others
Global Polymerase Chain Reaction (PCR) Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals & Clinics
Pharmaceutical & Biotechnology Industries
Diagnostic Centers
Academic & Research Organizations
Global Polymerase Chain Reaction (PCR) Market Size & CAGR (2025-2032)
North America (Type, Product, Indication, End User)
US
Canada
Europe (Type, Product, Indication, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type, Product, Indication, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type, Product, Indication, End User)
Brazil
Rest of Latin America
Middle East & Africa (Type, Product, Indication, End User)
